|
I.G. Gordeev (1), N.A. Volov (1), M.N. Arefiev (2), R.S. Ilchenko (2)
QRS complex fragmentation in ST-segment elevation myocardial infarction: a clinical case
|
№9 / 2019
|
|
M.I. Ivanova (1), P.P. Ikonnikov (2), E.L. Belyaevа (1)
A clinical case of infarction-like myocarditis
|
№9 / 2019
|
|
E.Yu. Plotnikova, A.S. Sukhikh, T.Yu. Gracheva
Generics: world and domestic practice
|
№9 / 2019
|
|
D.V. Nebieridze, N.M. Akhmedzhanov, A.S. Safaryan
Current management strategy for high-risk hypertensive patients – focus on lipid-lowering therapy
|
№9 / 2019
|
|
O.V. Vorob’eva
Cerebral microangiopathy associated with age and/or arterial hypertension: clinical and pathogenetic aspects, approaches to therapy
|
№9 / 2019
|
|
A.E. Bagriy (1), E.S. Mikhailichenko (2), L.I. Kardashevskaya (1), E.V. Shchukina (1)
Potentials for dual RAAS blockade in the correction of endothelial dysfunction in hypertensive patients: comparative study
|
№9 / 2019
|
|
N.V. Korneeva, B.Z. Sirotin
Microcirculation parameters in hypertensive patients who stopped smoking, depending on the duration of smoking cessation
|
№9 / 2019
|
|
A.V. Breus, A.A. Feskova, A.Ya. Kravchenko
Psycho-emotional status and quality of life in patients with arterial hypertension and subclinical hypothyroidism: an observational case-control study
|
№9 / 2019
|
|
Ya.I. Ashikhmin (1), Yu.E. Azimova (1, 2)
Anti-CGRP monoclonal antibodies: focus on safety
|
№9 / 2019
|
|
A.A. Belyaev
Cerebrovascular diseases and atherosclerotic carotid stenosis: surgical and pharmacological approaches to therapy
|
№9 / 2019
|
|
N.P. Lyamina (1), A.V. Kosareva (2)
The justified position of rosuvastatin in therapeutic practice
|
№9 / 2019
|
|
T.M. Ostroumova (1), O.D. Ostroumova (1, 2), A.I. Kochetkov (2), A.P. Pereverzev (2)
Drug-induced nightmares
|
№9 / 2019
|
Русский
